パロキセチン錠５ｍｇ「明治」
基本情報
| 項目 | 値 |
|---|---|
| DrugBank ID | DB00715 |
| エビデンスレベル | L5（計算予測のみ） |
| 予測適応症数 | 32 |
| 日本商品名（例） | パロキセチン塩酸塩１０ｍｇ錠, パロキセチン塩酸塩２０ｍｇ錠, パロキセチン塩酸塩５ｍｇ錠 |
予測適応症（TxGNN）
以下は TxGNN モデルにより予測された潜在的新適応症です。スコアが高いほど関連性が高いと予測されています。
| # | 適応症 | スコア | ソース |
|---|---|---|---|
| 1 | dysthymic disorder | 99% | DL |
| 2 | major depressive disorder | 99% | DL |
| 3 | endogenous depression | 99% | DL |
| 4 | Ohdo syndrome and variants | 99% | DL |
| 5 | obsessive-compulsive disorder | 98% | DL |
| 6 | unipolar depression | 98% | DL |
| 7 | anxiety disorder | 98% | DL |
| 8 | melancholia | 98% | DL |
| 9 | blepharophimosis - intellectual disability syndrome, Ohdo type | 98% | DL |
| 10 | neurotic depression | 98% | DL |
| 11 | benign paroxysmal torticollis of infancy | 98% | DL |
| 12 | agoraphobia | 97% | DL |
| 13 | schizoid personality disorder | 97% | DL |
| 14 | histrionic personality disorder (disease) | 97% | DL |
| 15 | schizotypal personality disorder | 97% | DL |
| 16 | paranoid personality disorder | 97% | DL |
| 17 | Keppen-Lubinsky syndrome | 97% | DL |
| 18 | ligneous conjunctivitis | 97% | DL |
| 19 | neurotic disorder | 96% | DL |
| 20 | congenital isolated adrenocorticotropic hormone deficiency (disease) | 96% | DL |
| 21 | migraine disorder | 96% | DL |
| 22 | migraine with brainstem aura | 96% | DL |
| 23 | phobic disorder | 95% | DL |
| 24 | autosomal dominant slowed nerve conduction velocity | 95% | DL |
| 25 | myofascial pain syndrome | 94% | DL |
| 26 | childhood apraxia of speech | 94% | DL |
| 27 | vitamin B12-responsive methylmalonic acidemia | 94% | DL |
| 28 | dependent personality disorder | 92% | DL |
| 29 | avoidant personality disorder | 91% | DL |
| 30 | narcissistic personality disorder | 90% | DL |
| 31 | post-traumatic stress disorder | 83% | DL |
| 32 | social phobia | 0% | DL |
免責事項
これらの予測は研究目的のみであり、医療アドバイスを構成するものではありません。 臨床応用には必ず適切な検証が必要です。